Trials / Completed
CompletedNCT00828659
Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users
A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the abuse potential of lorcaserin in healthy recreational polydrug users.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | Active Comparator #1 | |
| DRUG | Active Comparator #2 | |
| DRUG | Active Comparator #3 | |
| DRUG | Lorcaserin Dose #1 | |
| DRUG | Lorcaserin Dose #2 | |
| DRUG | Lorcaserin Dose #3 |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2009-01-26
- Last updated
- 2019-09-12
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00828659. Inclusion in this directory is not an endorsement.